Skip to contentSkip to filters

We use cookies for analytics.

Podcast

Clinical Pharmacology Podcast

  • 10 episodes
  • Latest episode Oct 26, 2026
Related content

Topics

Recent episodes

Nathan Teuscher explains how measurements from different occasions vary within a patient and why individual estimates shrink toward a population average. He discusses how both effects can change the interpretation of population pharmacokinetic models.

Hosted by Nathan Teuscher

Published Oct 26, 2026 · 23 min

Nathan Teuscher examines the relationship between drug exposure and response. He covers the questions an exposure–response analysis can answer, when it fits into development and which modeling tools can be used.

Hosted by Nathan Teuscher

Published Oct 2, 2026 · 30 min

Nathan Teuscher reviews how kidney and liver function influence drug exposure. He discusses how pharmacokinetic studies analyze data from participants with renal or hepatic impairment.

Hosted by Nathan Teuscher

Published Aug 24, 2026 · 29 min

Nathan Teuscher describes how bioequivalence studies support generic drug approval, from choosing a study design through interpreting the statistical comparison. He also covers uses of bioequivalence elsewhere in drug development.

Hosted by Nathan Teuscher

Published May 25, 2026 · 24 min

Nathan Teuscher compares the different definitions of volume of distribution, explains how their values are calculated and discusses which interpretation is relevant to a drug-development decision.

Hosted by Nathan Teuscher

Published Apr 20, 2026 · 19 min

Nathan Teuscher and Michael Stackhouse discuss modern statistical programming in drug development, the proposed move from SAS transport files to Dataset-JSON in regulatory submissions, and the role of AI in data programming.

Hosted by Nathan Teuscher

Published Mar 16, 2026 · 45 min

Nathan Teuscher and Wouter Vaes discuss how accelerator mass spectrometry can be used to study drug metabolism and pharmacokinetics early in clinical development, including work on oncology drugs and absolute bioavailability.

Hosted by Nathan Teuscher

Published Feb 16, 2026 · 38 min

Nathan Teuscher and Aruna Dhontabhaktuni discuss how large language models can support regulatory intelligence in drug development. Their conversation examines the work involved in gathering and interpreting regulatory information.

Hosted by Nathan Teuscher

Published Jan 19, 2026 · 21 min

Nathan Teuscher compares approaches to model-informed drug development and discusses when each type of model can inform a decision during a development program.

Hosted by Nathan Teuscher

Published Dec 22, 2025 · 28 min

Nathan Teuscher and Ahmed Elmokadem discuss quantitative systems pharmacology and how models can connect biological mechanisms with evidence used in clinical development decisions.

Hosted by Nathan Teuscher

Published Nov 24, 2025 · 45 min